Cardiologist voices concerns over testosterone therapy

During these unprecedented times, Clark, Perdue, & List Co, LPA is here to fully support your needs in a timely and safe manner. COVID-19 should not affect your ability to investigate a personal injury case. We currently remain open and are still accepting new cases. With your safety top of mind, we are scheduling all meetings via telephone or video conference at this time.

A recently released study indicates that use of testosterone therapy greatly increases the risk of heart attacks. Testosterone therapy has been recommended for treatment of hypogonadism, which causes abnormally low testosterone levels. However, only half of men taking the therapy have been diagnosed with this condition and about 25 percent of men have never even had their levels checked.

Cardiologist Steven Nissen believes the Food and Drug Administration should require companies that market testosterone therapy to conduct rigorous clinical trials evaluating the risks of heart attacks.

Nissen, who is chair of cardiovascular medicine at the Cleveland Clinic, stated that prescribing testosterone therapy to thousands of men who may not really need or benefit from it is “a gigantic experiment, and I’m extremely concerned.”

The new study that found the correlation between heart attacks and testosterone therapy noted that most of the heart attacks occurred in the first 90 days after the prescription was written.

Clark, Perdue and List, Ohio pharmaceutical injury attorneys, are investigating claims for injury and death from heart attacks connected to testosterone therapy. If you or someone you care about was taking testosterone therapy and suffered a heart attack, you may be entitled to compensation. Contact the Ohio Testosterone Injury lawyers at Clark, Perdue & List.